NDC codes

FDA NDC Directory
Product NDC (as listed)51672-1374Labeler and product segments. Claims need a package NDC.
Product NDC at billing width51672-1374Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
51672-1374-251672137402516721374021 TUBE in 1 CARTON (51672-1374-2) / 30 g in 1 TUBEMarketed from Apr 3, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Tazarotene
Generic name (nonproprietary)
tazarotene
Active ingredients
Tazarotene — 1 mg/g
Dosage form
Cream
Route
Topical
Labeler
Sun Pharmaceutical Industries, Inc.NDC labeler code 51672
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 208258
Marketing start
Listing expires
Other FDA classes
Retinoids (Chemical structure)
Identifiers
Product ID 51672-1374_39620f25-787e-f51b-e063-6294a90a36deSPL ID 39620f25-787e-f51b-e063-6294a90a36deSPL set ID 34d79c31-1568-4797-a4f5-31200c7788dbRxCUI 313200UNII 81BDR9Y8PS
Pharmacologic class
Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451672137402 followed by a unit qualifier and the quantity

Package 51672-1374-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Tazarotene cream, 0.1% is indicated as an adjunctive agent for use in the mitigation (palliation) of facial fine wrinkling, facial mottled hyper-and hypopigmentation, and benign facial lentigines in patients who use comprehensive skin care and sunlight avoidance programs. Tazarotene cream, 0.1% is a retinoid indicated as an adjunctive agent for use in the mitigation (palliation) of facial fine wrinkling, facial mottled hyper- and hypopigmentation, and benign facial lentigines in patients who use comprehensive skin care and sunlight avoidance programs. ( 1 ) Limitations of Use: Does not eliminate or prevent wrinkles or restore more youthful skin. ( 1 ) Does not repair sun damaged skin or reve…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51672-1374

What is NDC 51672-1374?
51672-1374 is the product NDC for Tazarotene, Tazarotene 1 mg/g cream, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Tazarotene.
What is the active ingredient?
Tazarotene.
Who is the labeler?
Sun Pharmaceutical Industries, Inc., NDC labeler code 51672. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tazarotene?
14 other product NDCs are listed under this name. See all Tazarotene NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tazarotene NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
TazaroteneTazarotene .5 mg/gCreamTopicalCosette Pharmaceuticals, Inc.0713-076500713-0765-3100713-0765-60
TazaroteneTazarotene .5 mg/gGelCutaneousSolaris Pharma Corporation73473-30973473-0309-1073473-0309-30
TazaroteneTazarotene 1 mg/gGelCutaneousSolaris Pharma Corporation73473-31073473-0310-1073473-0310-30
TazaroteneTazarotene .5 mg/gCreamTopicalPadagis Israel Pharmaceuticals Ltd45802-70645802-0706-9445802-0706-96
TazaroteneTazarotene .5 mg/gCreamTopicalBryant Ranch Prepack72162-242072162-2420-0372162-2420-06
TazaroteneTazarotene .5 mg/gGelTopicalPadagis Israel Pharmaceuticals Ltd45802-43645802-0436-0145802-0436-94
TazaroteneTazarotene 1 mg/gGelTopicalPadagis Israel Pharmaceuticals Ltd45802-44245802-0442-0145802-0442-94
TazaroteneTazarotene 1 mg/gGelTopicalBryant Ranch Prepack72162-220272162-2202-03
TazaroteneTazarotene 1 mg/gGelTopicalCosette Pharmaceuticals, Inc.0713-080400713-0804-3100713-0804-99
TazaroteneTazarotene .5 mg/gGelTopicalCosette Pharmaceuticals, Inc.0713-080500713-0805-3100713-0805-99

All 15 Tazarotene NDCs

Other NDCs under ANDA 208258

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208258
ProductStrengthForm · routeLabelerProduct NDC
TazaroteneTazarotene 1 mg/gCreamTopicalSun Pharmaceutical Industries, Inc.51672-1373

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in